SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-18-003528
Filing Date
2018-12-10
Accepted
2018-12-10 17:26:20
Documents
64
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 c92444_10q.htm 10-Q 421348
2 c92444_ex31-1.htm EX-31.1 7320
3 c92444_ex31-2.htm EX-31.2 7403
4 c92444_ex32-1.htm EX-32.1 3202
5 c92444_ex32-2.htm EX-32.2 3219
  Complete submission text file 0000930413-18-003528.txt   3268366

Data Files

Seq Description Document Type Size
6 enz-20181031.xml EX-101.INS 610138
7 enz-20181031.xsd EX-101.SCH 48583
8 enz-20181031_cal.xml EX-101.CAL 32748
9 enz-20181031_def.xml EX-101.DEF 219472
10 enz-20181031_lab.xml EX-101.LAB 320620
11 enz-20181031_pre.xml EX-101.PRE 219347
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 181227123
SIC: 8071 Services-Medical Laboratories